한글목차

금연 및 니코틴 의존증 치료 시장 규모는 2025년 364억 6,000만 달러에서 2026-2034년에 CAGR 10.66%로 성장하며, 2034년에는 907억 3,000만 달러에 달할 것으로 예측되고 있습니다.

금연 및 니코틴 중독 치료 시장은 공중보건 정책과 흡연의 위험성에 대한 인식이 높아지면서 효과적인 금연 솔루션에 대한 수요가 증가함에 따라 패러다임의 변화를 경험하고 있습니다. 금연을 목표로 하는 사람들이 늘어나면서 니코틴 대체요법(NRT), 처방약, 행동지원 프로그램 시장이 확대되고 있습니다. 이러한 성장은 흡연과 관련된 건강 문제 증가로 인해 더욱 가속화되고 있으며, 정부와 의료 기관은 금연을 원하는 개인에게 지원과 자원을 제공하는 종합적인 금연 프로그램에 투자하고 있습니다.

또한 디지털 헬스 기술의 등장은 금연 지원의 지형을 바꾸고 있습니다. 모바일 애플리케이션과 온라인 플랫폼은 금연을 목표로 하는 개인에게 맞춤형 지원, 진행 상황 관리 및 동기 부여를 제공하는 귀중한 툴로 부상하고 있습니다. 이러한 디지털 솔루션은 종종 행동 과학의 원리를 도입하여 사용자에게 갈망과 유혹을 관리할 수 있는 개인화된 전략을 제공합니다. 기술이 발전함에 따라 인공지능과 머신러닝을 이러한 플랫폼에 통합함으로써 그 효율성이 향상되고, 사용자에 대한 보다 정밀한 개입과 지원이 가능해질 것입니다.

또한 전자담배와 가열식 담배 제품 등 대체 니코틴 공급 시스템의 보급 확대가 금연 시장을 재편하고 있습니다. 이러한 제품들은 종종 덜 해로운 대체품으로 선전되고 있지만, 여전히 공중 보건 문제를 안고 있습니다. 규제 당국이 이러한 대체품의 장기적인 영향을 평가하고 있는 가운데, 금연 시장은 적응해야 하며, 금연을 원하는 개인의 다양한 니즈를 충족시킬 수 있는 종합적인 솔루션을 제공해야 합니다. 이처럼 금연 및 니코틴 중독 치료 시장은 혁신과 기술 혁신, 그리고 공중보건 성과 향상을 위한 공동의 노력에 힘입어 큰 폭의 성장이 기대되는 상황입니다.

목차

제1장 서론

제2장 개요

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 금연 및 니코틴 의존증 치료 시장 : 유형별

제5장 세계의 금연 및 니코틴 의존증 치료 시장 : 폼별

제6장 세계의 금연 및 니코틴 의존증 치료 시장 : 유통 채널별

제7장 세계의 금연 및 니코틴 의존증 치료 시장 : 지역별

제8장 경쟁 구도

제9장 기업 개요

영문목차

The Smoking Cessation and Nicotine De-Addiction Market size is expected to reach USD 90.73 Billion in 2034 from USD 36.46 Billion (2025) growing at a CAGR of 10.66% during 2026-2034.

The smoking cessation and nicotine de-addiction market is witnessing a paradigm shift as public health initiatives and growing awareness of the dangers of smoking drive demand for effective cessation solutions. With an increasing number of individuals seeking to quit smoking, the market for nicotine replacement therapies (NRTs), prescription medications, and behavioral support programs is expanding. This growth is further fueled by the rising prevalence of smoking-related health issues, prompting governments and healthcare organizations to invest in comprehensive smoking cessation programs that provide support and resources for individuals looking to quit.

Moreover, the advent of digital health technologies is transforming the smoking cessation landscape. Mobile applications and online platforms are emerging as valuable tools that offer personalized support, tracking, and motivation for individuals on their journey to quit smoking. These digital solutions often incorporate behavioral science principles, providing users with tailored strategies to manage cravings and triggers. As technology continues to evolve, the integration of artificial intelligence and machine learning into these platforms will enhance their effectiveness, enabling more precise interventions and support for users.

Additionally, the increasing popularity of alternative nicotine delivery systems, such as e-cigarettes and heated tobacco products, is reshaping the smoking cessation market. While these products are often marketed as less harmful alternatives, they still pose challenges for public health. As regulatory bodies assess the long-term effects of these alternatives, the smoking cessation market will need to adapt, offering comprehensive solutions that address the diverse needs of individuals seeking to quit. The smoking cessation and nicotine de-addiction market is thus positioned for significant growth, driven by innovation, technology, and a collective commitment to improving public health outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Nicotine Replacement Therapy
• Drug Therapy
• E-cigarettes

By Form

• Gum
• Inhaler
• Tablet
• Others

By Distribution Channel

• Hospital Pharmacies
• Online
• Drug Stores and Retail Pharmacies

COMPANIES PROFILED

• Rusan Pharma Ltd, Dr Reddys Laboratories Ltd, Imperial Brands Plc, Zydus Group, British American Tobacco Plc, Perrigo Company Plc, Johnson and Johnson Inc, Njoy LLC, Cipla Ltd, GlaxoSmithKline Plc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Nicotine Replacement Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Drug Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. E-cigarettes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY FORM 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Form
• 5.2. Gum Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Inhaler Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Tablet Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Online Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Drug Stores and Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Form
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Form
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Form
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Form
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Form
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Rusan Pharma Ltd
  • 9.2.2 Dr. Reddy'S Laboratories Ltd
  • 9.2.3 Imperial Brands Plc
  • 9.2.4 Zydus Group
  • 9.2.5 British American Tobacco Plc
  • 9.2.6 Perrigo Company Plc
  • 9.2.7 Johnson And Johnson Inc
  • 9.2.8 Njoy LLC
  • 9.2.9 Cipla Ltd
  • 9.2.10 GlaxoSmithKline Plc